FDA Approves Monthly Buprenorphine MAT for Opioid Use Disorder

Drug Industry Daily
A A
The FDA approved Invidior’s Sublocade, the first once-monthly buprenorphine injectable as a medication-assisted treatment for opioid use disorder.

To View This Article:

Login

Subscribe To Drug Industry Daily